BNO — Bionomics Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$14.69m
- -AU$15.40m
- AU$0.26m
Brief: Bionomics Ltd Updates On Possible Capital Distribution
Australia Stock Exchange release from BIONOMICS : PRE_NR Ends: 10:07:50
Australia Stock Exchange release from BIONOMICS : Update on Possible Capital Distribution
Australia Stock Exchange release from BIONOMICS : Bionomics Receives ASX Waiver from LR 10.13.5
Australia Stock Exchange release from BIONOMICS : Section 708A Notice
Australia Stock Exchange release from BIONOMICS : Application for quotation of securities - BNO
Brief: Bionomics Receives FDA Clearance Of IND For Evaluation Of BNC210 In A Phase 2 Social Anxiety Disorder Prevail Study
Brief: Bionomics Receives FDA Clearance Of IND For Evaluation Of BNC210 In Phase 2 Social Anxiety Disorder Prevail Study
Australia Stock Exchange release from BIONOMICS : FDA Clears BNC210 Ph2 Social Anxiety Disorder IND (PREVAIL)
Australia Stock Exchange release from BIONOMICS : 2021 Notice of AGM/Proxy Form
Australia Stock Exchange release from BIONOMICS : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from BIONOMICS : PRE_NR Ends: 17:41:28
Australia Stock Exchange release from BIONOMICS : Jobkeeper Payments Notification
Australia Stock Exchange release from BIONOMICS : 2021 Corporate Governance Statement and Appendix 4G
Australia Stock Exchange release from BIONOMICS : 2021 Annual Report
Australia Stock Exchange release from BIONOMICS : Closing Date for Nomination of Director
Australia Stock Exchange release from BIONOMICS : Notification of cessation of securities - BNO
Brief: Bionomics Says Decided To Proceed With Evaluating Its BNC210 For Acute Treatment Of Social Anxiety Disorder
Australia Stock Exchange release from BIONOMICS : PRE_NR Ends: 10:03:50